Clinical Trials Logo

Clinical Trial Summary

The present study investigated the effect of routine calcium and vitamin D supplementation and tried to find the predictors for postoperative hypocalcemia in patients with thyroid cancer.


Clinical Trial Description

The present study investigated the effect of routine calcium and vitamin D supplementation and tried to find the predictors for postoperative hypocalcemia in patients with thyroid cancer. Demographic data, including age, sex, pathologic features, and postoperative laboratory test results were analyzed, as was the development of symptomatic hypocalcemia, defined as an ionized calcium concentration below 4.6 mg/dL (normal range, 4.6-5.4 mg/dL) associated with hypocalcemic symptoms. Hypocalcemia was considered permanent in patients who required calcium supplementation for longer than 6 months after thyroidectomy.

Serum concentrations of PTH and ionized calcium were measured 1 and 14 days postoperatively. Patients in the routine calcium group received oral supplements of 1,500 mg/day elemental calcium and 1,000 IU/day cholecalciferol for 2 weeks, beginning on the first postoperative day (POD) to the 14th POD, whereas patients in the control group received no supplementation. If symptomatic hypocalcemia developed, patients in both groups received 2.0 g of intravenous calcium, followed by oral supplementation with 3,000-4,000 mg/day elemental calcium and 1,000-2,000 IU/day cholecalciferol up to the 14th POD. If hypocalcemic symptoms were persistent or worsening 2 hours after calcium administration, patients were administered another intravenous calcium supplementation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03484416
Study type Interventional
Source Ewha Womans University Mokdong Hospital
Contact
Status Completed
Phase N/A
Start date March 1, 2016
Completion date May 30, 2017

See also
  Status Clinical Trial Phase
Terminated NCT03986593 - Cryoablation of Bone Metastases From Endocrine Tumors N/A
Completed NCT01182285 - A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin Phase 2
Recruiting NCT02112370 - Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy Phase 3
Not yet recruiting NCT04883294 - Validation of the Diagnostic Accuracy of the Electronic Nose in the Detection of Thyroid Cancer
Completed NCT03037385 - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Phase 1/Phase 2
Completed NCT06275425 - Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational Anesthesia N/A
Completed NCT01617694 - Comparison Between Remifentanil Target-controlled Infusion and Dexmedetomidine Bolus Administration for Smooth Emergence From General Sevoflurane Anesthesia N/A
Completed NCT01226914 - A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICELâ„¢ Fibrin Sealant in Thyroidectomy N/A
Completed NCT01137097 - Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC Phase 2/Phase 3
Completed NCT03012620 - Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types Phase 2
Completed NCT04574947 - Lidocaine And Neuromonitoring in Thyroid Surgery Phase 4
Completed NCT03392402 - Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules
Completed NCT01308320 - Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General Anaesthesia Phase 4
Completed NCT05068687 - Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT N/A
Terminated NCT00647140 - Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer Phase 2
Not yet recruiting NCT00385983 - Total Thyroidectomy With Harmonic Scalpel® Phase 4
Completed NCT01103557 - Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma N/A